About Us
Brands in Conversation
Academic Connect
Regional Trailblazers
Marketers in Conversation
Marketing Guru Speaks
Case Studies
Contact Us
Contribute Articles
Market Intelligence & Research
Skilling Programs
Internship
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Friday, March 27, 2026
Sign in / Join
Home
Disclaimer
Facebook
Instagram
Linkedin
Twitter
WhatsApp
About Us
Brands in Conversation
Academic Connect
Regional Trailblazers
Marketers in Conversation
Marketing Guru Speaks
Case Studies
Contact Us
Contribute Articles
Market Intelligence & Research
Skilling Programs
Internship
Search
Home
Tags
Granules Pharmaceuticals
Tag: Granules Pharmaceuticals
Brands in Conversation
Granules Pharmaceuticals, Inc. Receives FDA Tentative Approval with 180-Day Exclusivity for Generic Amphetamine Extended-Release Tablets (gDYANAVEL XR)
Author
-
January 9, 2026
0
Brands in Conversation
Granules Pharmaceuticals Inc. Receives FDA Tentative Approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets (ADZENYS XR-ODT®)
Author
-
December 22, 2025
0
Brands in Conversation
Granules Strengthens ADHD Portfolio with FDA Approval for Lisdexamfetamine Dimesylate Capsules
Passionate in Marketing
-
January 30, 2025
0
Brands in Conversation
Granules India Limited Announces FDA Approval for ADHD Treatment, Addressing Drug Shortages in the U.S.
Passionate in Marketing
-
December 17, 2024
0